Pliant Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 46.96 million compared to USD 37.55 million a year ago. Basic loss per share from continuing operations was USD 0.78 compared to USD 0.67 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.73 USD | -5.00% | -16.63% | -29.71% |
May. 14 | Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading | MT |
May. 14 | Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.71% | 768M | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- PLRX Stock
- News Pliant Therapeutics, Inc.
- Pliant Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024